January 2, 2018 08:01 AM ESTUpdated 02:18 PM
Financing
Startups

Ex-Pfiz­er CEO's start­up Cen­trex­ion gets $67M for PhI­II painkiller

Brittany Meiling

Cen­trex­ion Ther­a­peu­tics, a Boston-based start­up led by ex-Pfiz­er CEO Jeff Kindler, just raised $67 mil­lion to bring its painkiller drug in­to Phase III tri­als. If …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times